
UB566
TargetsHer2/Her2
IndicationsSolid tumour
ClinicalCN - III
TherapeuticsOncology
ModalitiesAntibody
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →